881 reports of this reaction
1.9% of all ESZOPICLONE reports
#8 most reported adverse reaction
SOMNOLENCE is the #8 most commonly reported adverse reaction for ESZOPICLONE, manufactured by Waylis Therapeutics LLC. There are 881 FDA adverse event reports linking ESZOPICLONE to SOMNOLENCE. This represents approximately 1.9% of all 47,350 adverse event reports for this drug.
Patients taking ESZOPICLONE who experience somnolence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SOMNOLENCE is a less commonly reported adverse event for ESZOPICLONE, but still significant enough to appear in the safety profile.
In addition to somnolence, the following adverse reactions have been reported for ESZOPICLONE:
The following drugs have also been linked to somnolence in FDA adverse event reports:
SOMNOLENCE has been reported as an adverse event in 881 FDA reports for ESZOPICLONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SOMNOLENCE accounts for approximately 1.9% of all adverse event reports for ESZOPICLONE, making it a notable side effect.
If you experience somnolence while taking ESZOPICLONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.